Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by NanoVibronix, Inc.

< Previous 1 2 Next >
NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guard
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Issues Letter to Shareholders
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Issues Letter to Shareholders
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS)
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Announces Positive Results from Independent Product Trial of UroShield for Patients with a Spinal Cord Injury
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Regains Nasdaq Compliance
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix to Launch Rental Program for PainShield and UroShield
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Announces Reverse Stock Split
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Provides Update on Expanding Access to PainShield
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Announces Partnership with Peak Medical, Ltd.
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Announces $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Announces Interim Results of Clinical Study for UroShield
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Provides Business Update in Letter to Shareholders
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix UroShield Approved for Sale through NHS Internal Supply Chain Contract
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Sets Date for Annual Shareholder Meeting
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Announces Distribution of Series F Preferred Stock to Holders of its Common Stock
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Provides Business Update in Letter to Shareholders
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Announces Webinar Series to Promote UroShield
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Strengthening Supply Chain Increasing Efficiency and Scalability
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Reports First Quarter 2022 Financial Results
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Announces FDA 510(k) Submission for PainShield® MD PLUS
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Adds Additional Product to Federal Supply Schedule
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
NanoVibronix Advances Efforts to Achieve NHS Approval
From NanoVibronix, Inc.
Via Business Wire
Tickers NAOV
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.